We are live on ! Find out more
NEO icon

NeoGenomics

137 hedge funds and large institutions have $493M invested in NeoGenomics in 2016 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 62 increasing their positions, 36 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

899% more call options, than puts

Call options by funds: $1.08M | Put options by funds: $108K

72% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 36

2% more capital invested

Capital invested by funds: $483M → $493M (+$9.23M)

0% more funds holding in top 10

Funds holding in top 10: 66 (0)

12% less funds holding

Funds holding: 155137 (-18)

78% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 23

Holders
137
Holders Change
-18
Holders Change %
-11.61%
% of All Funds
3.66%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.16%
New
5
Increased
62
Reduced
36
Closed
23
Calls
$1.08M
Puts
$108K
Net Calls
+$971K
Net Calls Change
+$291K

NEO Hedge Fund Activity: Q3 2016 in Review

137 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q3 2016, worth a combined $493M — up 1.9% from $483M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of NEO and 5 opened new positions — a net loss of 18 holders — while 36 trimmed existing stakes and 62 added.

The largest buyer was Next Century Growth Investors, adding an estimated $4.18M. The largest seller was Kopp Investment Advisors, cutting an estimated $8.2M.

  • 137 institutional investors held NeoGenomics (NEO) as of Q3 2016, down from 155 in Q2 2016.
  • Funds reported $493M of NeoGenomics stock for Q3 2016, up 1.9% quarter-over-quarter.
  • 5 funds opened new NeoGenomics positions in Q3 2016 and 23 closed out, a net change of -18 holders.
  • The largest NeoGenomics buyer in Q3 2016 was Next Century Growth Investors, an estimated $4.18M added.
  • The largest NeoGenomics seller in Q3 2016 was Kopp Investment Advisors, an estimated $8.2M sold.

Based on aggregated 13F filings for Q3 2016.